Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Bridgewater Associates LP

Bridgewater Associates LP lowered its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 12.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 408,755 shares of the company's stock after selling 56,504 shares during the period. Bridgewater Associates LP owned about 0.17% of Cardinal Health worth $48,343,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Rothschild Investment LLC raised its position in Cardinal Health by 10.1% in the fourth quarter. Rothschild Investment LLC now owns 858 shares of the company's stock worth $101,000 after acquiring an additional 79 shares in the last quarter. Private Trust Co. NA raised its holdings in Cardinal Health by 11.0% during the fourth quarter. Private Trust Co. NA now owns 930 shares of the company's stock worth $110,000 after purchasing an additional 92 shares during the last quarter. Checchi Capital Advisers LLC boosted its position in Cardinal Health by 2.7% during the fourth quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company's stock worth $411,000 after purchasing an additional 93 shares in the last quarter. TIAA Trust National Association increased its position in shares of Cardinal Health by 4.5% in the fourth quarter. TIAA Trust National Association now owns 2,183 shares of the company's stock valued at $258,000 after buying an additional 94 shares in the last quarter. Finally, MWA Asset Management raised its stake in shares of Cardinal Health by 2.9% during the 4th quarter. MWA Asset Management now owns 3,324 shares of the company's stock worth $393,000 after buying an additional 95 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Stock Performance

Shares of NYSE:CAH traded up $0.25 during trading on Friday, reaching $134.61. 2,350,067 shares of the stock were exchanged, compared to its average volume of 2,193,837. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $139.50. The firm's 50-day moving average price is $129.90 and its 200 day moving average price is $122.98. The firm has a market cap of $32.52 billion, a price-to-earnings ratio of 25.11, a price-to-earnings-growth ratio of 1.49 and a beta of 0.61.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, beating analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, equities research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st were given a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a yield of 1.50%. The ex-dividend date was Tuesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is presently 37.69%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on CAH. Morgan Stanley upped their price target on shares of Cardinal Health from $136.00 to $142.00 and gave the company an "overweight" rating in a report on Friday, January 31st. TD Cowen raised Cardinal Health from a "hold" rating to a "buy" rating and boosted their price target for the stock from $130.00 to $144.00 in a report on Wednesday, January 8th. Evercore ISI raised Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 price objective on the stock in a research note on Tuesday, January 7th. Citigroup upped their target price on shares of Cardinal Health from $120.00 to $129.00 and gave the company a "neutral" rating in a report on Friday, January 10th. Finally, Argus set a $148.00 price objective on shares of Cardinal Health in a research report on Tuesday, February 4th. Four equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $140.86.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.